type here...

CATEGORIES

Cardiovascular

LATEST

1...141516...20Page 15 of 20

TRENDING

EDITORS CHOICE

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Don’t Be Fooled — Not all Fruits and Vegetables are “Dirty.”

Michael Hunter, MD -
I RECENTLY READ ABOUT THE "DIRTY DOZEN," a group of pesticide-containing fruits and vegetables. The Environmental Working Group gives us a "dirty dozen" list of fruits...

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Gil Bashe, Medika Life Editor -
EDS Subtyping May Not Be a Harmless Convention, But a Recipe for Patient Danger

Congenital Heart Defects

Medika Life -
Congenital heart defects, or diseases, are problems with the heart’s structure that are present at birth. They may change the normal flow of blood through the heart.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories